1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
66EE90AE92A74547765257EF400405565
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/6EE90AE92A74547765257EF400405565!OpenDocument
18
19OpenDocument
203.236.86.184
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Market Research, Analytics and Forecasting » Process Excellence and Productivity Management

Document Excerpt: Enabling Marketing Insights and Superior Competitiveness Through Faster Market Research Approvals: Managing Cycle Times

DB Image

ID: MD-485


Features:

16 Info Graphics

15 Data Graphics

200+ Metrics

7 Narratives

8 Best Practices


Pages/Slides: 4


Published: Pre-2019


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER

To download this excerpt, click "
Download Free Excerpt".


To return to the study abstract to purchase the full study
- click here

This excerpt includes research findings and metrics from document #5384 "Enabling Marketing Insights and Superior Competitiveness Through Faster Market Research Approvals: Managing Cycle Times."


Industries Profiled:
Pharmaceutical; Biotech; Manufacturing; Consumer Products; Diagnostic; Medical Device; Chemical; Health Care; Technology; Biopharmaceutical; Clinical Research; Laboratories


Companies Profiled:
Abbvie; actavis; Amgen; AstraZeneca; Bayer; Biogen; Boehringer Ingelheim; CSL Behring; Fresenius Kabi; Genentech; Grifols; Jazz Pharmaceuticals; Lilly; NeedleTech Products Inc.; Novartis; Novo Nordisk; Philips Healthcare; Roche; Sanofi; Teva Pharmaceutical Industries Ltd; UCB Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.